Michael Arnold

机构：Children's Hospital Colorado, University of Colorado Anschutz, University of Colorado Denver, Stanford University · ORCID：0000-0002-6921-3720

发表论文 390 篇 · 总被引 7748 次 · h-index 47

代表论文

• Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer (2023 · Nature Medicine · 被引 50)
• Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group (2024 · The Lancet Oncology · 被引 46)
• ALK-Rearranged Epithelioid Mesenchymal Neoplasm: Expanding the Spectrum of Tyrosine Kinase–Altered Mesenchymal Tumors (2023 · Modern Pathology · 被引 24)
• Polygenic risk scores, radiation treatment exposures and subsequent cancer risk in childhood cancer survivors (2024 · Nature Medicine · 被引 20)
• Association of Changes in Cancer Therapy Over 3 Decades With Risk of Subsequent Breast Cancer Among Female Childhood Cancer Survivors (2022 · JAMA Oncology · 被引 18)
• Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group (2024 · Pediatric Blood & Cancer · 被引 15)